Document Detail


Erythropoietin in the treatment of postural orthostatic tachycardia syndrome.
MedLine Citation:
PMID:  20838326     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Erythropoietin has been reported to improve symptoms of orthostatic intolerance in patients suffering from orthostatic hypotension. Previous reports on the use of erythropoietin in patients with postural orthostatic tachycardia (POTS) have included only a very small number of patients. In the current study, we report on the use of erythropoietin in patients with refractory POTS. The study was approved by the institutional review board. A retrospective nonrandomized analysis was performed on 39 patients evaluated at our autonomic center for POTS from 2003 to 2010. The diagnosis of POTS was based on patient history, physical examination, and response to head-up tilt-table testing. The mean follow-up period was 6 months. The patients were included in the current study if they had a diagnosis of POTS with severe symptoms of orthostatic intolerance and were refractory to the commonly used medications. All these patients were started on erythropoietin, and the response to therapy was considered successful if it provided symptomatic relief. We screened 200 patients with POTS and found 39 patients (age 33 ± 12, 37 females) to be eligible for inclusion in the current study. The response to the treatment was assessed subjectively in each patient and was obtained in a retrospective fashion from patient charts and physician communications. Eight (21%) patients demonstrated no improvement in symptoms after administration of erythropoietin. Three (8%) patients showed an improvement in symptoms of orthostatic intolerance of <3 months. Twenty-seven (71%) patients demonstrated sustained improvement in their symptoms of orthostatic intolerance at the mean follow-up of 6 months. Erythropoietin significantly improved sitting diastolic blood pressure but had no effect on other hemodynamic parameters. In a select group of POTS patients who are refractory to commonly used medications, erythropoietin may help improve symptoms of orthostatic intolerance.
Authors:
Khalil Kanjwal; Bilal Saeed; Beverly Karabin; Yousuf Kanjwal; Mujeeb Sheikh; Blair P Grubb
Related Documents :
11513446 - Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope:...
8297706 - Treatment of atrial fibrillation in a district general hospital.
2044546 - Electrophysiologic evaluation and outcome of patients with syncope of unknown origin.
22343066 - Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatri...
19134436 - Sorbitan sesquioleate, a common emulsifier in topical corticosteroids, is an important ...
8333766 - Resting energy expenditure and substrate oxidation rates in cystic fibrosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  19     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  92-5     Citation Subset:  IM    
Affiliation:
1Section of Electrophysiology, Division of Cardiology, Department of Medicine 2Division of Internal Medicine, Department of Medicine, Health Sciences Campus, The University of Toledo Medical Center, Toledo, OH.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amifostine-related Fever-rash during fractionated radiotherapy: diagnostic and predictive role of C-...
Next Document:  Carboplatin-induced hematuria in a patient of breast carcinoma. A case report.